| Does neutrophil-to-lymphocyte ratio predict active ulcerative colitis? E Posul, B Yilmaz, G Aktas, M Kurt Wiener Klinische Wochenschrift 127, 2015 | 125 | 2015 |
| Age-based computer-aided diagnosis approach for pancreatic cancer on endoscopic ultrasound images M Ozkan, M Cakiroglu, O Kocaman, M Kurt, B Yilmaz, G Can, U Korkmaz, ... Endoscopic Ultrasound 5 (2), 101-107, 2016 | 72 | 2016 |
| Nutritional habits in functional dyspepsia and its subgroups: a comparative study Z Göktaş, S Köklü, D Dikmen, Ö Öztürk, B Yılmaz, M Asıl, H Korkmaz, ... Scandinavian journal of gastroenterology 51 (8), 903-907, 2016 | 61 | 2016 |
| Endoscopic clips for the closure of acute iatrogenic perforations: Where do we stand? B Yılmaz, O Unlu, EC Roach, G Can, C Efe, U Korkmaz, M Kurt Digestive Endoscopy 27 (6), 641-648, 2015 | 52 | 2015 |
| Pregnancy in women with primary biliary cirrhosis. WS Efe C, Kahramanoğlu-Aksoy E, Yilmaz B, Ozseker B, Takci S, Roach EC ... Autoimmun Rev., 2014 | 48 | 2014 |
| Serum beta 2-microglobulin as a biomarker in inflammatory bowel disease. AS Yılmaz B, Köklü S, Yüksel O World J Gastroenterol., 2014 | 44* | 2014 |
| Chronic hepatitis B associated with hepatic steatosis, insulin resistance, necroinflammation and fibrosis B Yilmaz, S Koklu, H Buyukbayram, K Yalçin, U Korkmaz, E Posul, G Can, ... African health sciences 15 (3), 714-718, 2015 | 40 | 2015 |
| The relationship between fibrosis level and blood neutrophil to lymphocyte ratio in inactive hepatitis B carriers. HS Yilmaz B, Aydin H, Can G, Şentürk Z, Üstüner B, Yilmaz H, Öztürkler M ... Eur J Gastroenterol Hepatol., 2014 | 27 | 2014 |
| The Syk inhibitor fostamatinib decreases the severity of colonic mucosal damage in a rodent model of colitis G Can, S Ayvaz, H Can, S Demirtas, H Aksit, B Yilmaz, U Korkmaz, M Kurt, ... Journal of Crohn's and Colitis 9 (10), 907-917, 2015 | 26 | 2015 |
| Angiotensin-converting enzyme for noninvasive assessment of liver fibrosis in autoimmune hepatitis C Efe, M Cengiz, E Kahramanoglu-Aksoy, B Ylmaz, B Özseker, Y Beyazt, ... European Journal of Gastroenterology & Hepatology 27 (6), 649-654, 2015 | 23 | 2015 |
| Hepatic mass caused by Fasciola hepatica: a tricky differential diagnosis. GG Yilmaz B, Köklü S Am J Trop Med Hyg, 2013 | 23* | 2013 |
| Epidemiologic features of ınflammatory bowel disease in Western Blacksea region of Turkey for the last 10 years: retrospective cohort study. DÜ Can G, Poşul E, Yılmaz B, Can H, Korkmaz U, Ermiş F, Kurt M Korean J Intern Med., 2018 | 22* | 2018 |
| Are MR Compatible hemoclips safe after control of hemostasis? KB Kurt M, Posul E, Tekelioglu V, Yilmaz B, Korkmaz U endoscopy, 2014 | 22* | 2014 |
| Pembrolizumab in patients with advanced metastatic germ cell tumors AM Tsimberidou, HH Vo, V Subbiah, F Janku, S Piha-Paul, B Yilmaz, ... The Oncologist 26 (7), 558-e1098, 2021 | 21 | 2021 |
| The efficacy of tyrosine kinase inhibitor dasatinib on colonic mucosal damage in murine model of colitis. KT Can G, Ayvaz S, Can H, Karaboğa İ, Demirtaş S, Akşit H, Yılmaz B, Korkmaz ... Clin Res Hepatol Gastroenterol., 2016 | 14 | 2016 |
| Tyrosine kinase-2 gene polymorphisms are associated with ulcerative colitis and Crohn's disease in Turkish Population G Can, A Tezel, H Gürkan, H Can, B Yılmaz, G Ünsal, AR Soylu, HC Ümit Clinics and Research in Hepatology and Gastroenterology 39 (4), 489-498, 2015 | 14 | 2015 |
| Lesser celandine (pilewort) induced acute toxic liver injury: The first case report worldwide B Yilmaz, B Yilmaz, B Aktaş, O Unlu, EC Roach World Journal of Hepatology 7 (2), 285, 2015 | 14 | 2015 |
| Serum levels of nitrate, nitrite and advanced oxidation protein products (AOPP) in patients with nonalcoholic fatty liver disease A Çiftci, B Yilmaz, S Köklü, O Yüksel, M Özsoy, G Erden, G Öztürk, E Akbal, ... Acta Gastroenterol Belg 1, 2, 2015 | 14 | 2015 |
| Air leak syndrome after endoscopic retrograde cholangiopancreatography: A rare and fatal complication B Yilmaz, EC Roach, S Koklu, O Aydin, O Unlu, YA Kilic World Journal of Gastroenterology: WJG 21 (15), 4770, 2015 | 13 | 2015 |
| Infliximab leading to autoimmune hepatitis: an increasingly recognized side effect. KS Yilmaz B, Roach EC Dig Dis Sci., 2014 | 13 | 2014 |
